Market Overview

Prostate Cancer Educational Webcast Features Sex and Intimacy

Share:

As a part of Prostate Cancer Awareness Month in September, Us TOO
International Prostate Cancer Education and Support Network will present
a free educational webcast providing live video and audio from the
Prostate Cancer Pathways for Patients and Caregivers
. The event
will take place on Saturday, September 29, at Englewood Health in
Englewood, NJ. In addition to valuable information on prostate cancer
testing and treatment, the event will address maintaining sex and
intimacy after prostate cancer with a special presentation from renowned
expert and author, Dr. Anne Katz.

"Change in sexual function and incontinence are common side effects to
prostate cancer treatment, and they can be incredibly isolating," stated
Dr. Anne Katz. "Along with increasing awareness of prostate cancer
overall throughout September, we are bringing attention to the fact that
prostate cancer is often referred to as a ‘couple's disease' due to the
impact of its side effects on intimacy. Our goal is to provide men and
their partners with practical tips to get back on common ground, at a
time they need each other most."

Prostate Cancer Pathways for Patients and Caregivers will provide
education on various aspects of prostate cancer, a common health risk
for men as they age and a disease that has no symptoms until it is
advanced.

The New Jersey Pathways presenters will include:

  • Dr. Anne Katz, Certified Sexuality Counselor, Clinical Nurse
    Specialist at CancerCare Manitoba, Editor of the Oncology Nursing
    Forum, and Author
  • Dr. Stacy Loeb, Assistant Professor of Urology and Population Health
    at the New York University School of Medicine and Manhattan VA
  • Dr. Charles G. Drake, Director of Genitourinary Oncology and Associate
    Director for Clinical Research at the Herbert Irving Comprehensive
    Cancer Center, New York-Presbyterian/Columbia University Medical Center
  • Dr. Mazyar Ghanaat, Program Director of Urologic Oncology at Englewood
    Health

Englewood Health is at 350 Engle St. in Englewood, NJ, 07631. The
presentation will be in the Chiang Auditorium. Doors open at 9:00 am,
and the event runs from 10:00 am to 3:30 pm (Eastern Time). Registration
is free and attendees can participate in person or online via a live
webcast with audio and video from the event. A free lunch will be
provided to pre-registered, in-person attendees. An introduction to
meditation and acupuncture will also be available.

For free registration, visit: www.mainstreamchicago.com/ustoo-pathways-new-jersey
or contact Terri at 877-978-7866 or terril@ustoo.org.
Please note that on-site space is limited. While registering in-person
on the day of the event is an option, a seat in the auditorium and a
free lunch cannot be guaranteed.

The New Jersey Pathways event is the second of three regional events in
2018. The series began with a June 23 event in Seattle, WA, and includes
an event in Chicago, IL, on November 3. Each of the three Pathways
events features new content and unique presentations from top prostate
cancer physicians and medical experts.

The presenting sponsor of the New Jersey Pathways event is
Janssen Oncology. Supporting sponsors are Bayer, Sanofi Genzyme,
Astellas, Pfizer, Amgen, Genomic Health and Abbvie. The event host is
Englewood Health in collaboration with the Us TOO New Jersey and New
York Prostate Cancer Support Groups.

About Us TOO International

Us TOO International is a 501(c)3 nonprofit organization founded in 1990
that provides educational resources, support services and personal
connections to the prostate cancer community at no charge to help men
and their spouses/partners and loved ones make informed decisions about
prostate cancer detection, treatment options and related side effects.
In addition to more than 200 support groups throughout the U.S. and
abroad, Us TOO provides monthly newsletters, educational events, Inspire
online support community, toll-free HelpLine, printed materials and a
comprehensive website (www.ustoo.org).

View Comments and Join the Discussion!